These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5656614)

  • 1. Particulate matter in parenteral solutions.
    Med Lett Drugs Ther; 1968 May; 10(11):42-4. PubMed ID: 5656614
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous intravenous administration of drugs.
    Paris P; Hans P; Lamy M
    Acta Anaesthesiol Belg; 1983 Jun; 34(2):109-15. PubMed ID: 6613510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Counting of particulate matter in parenteral solutions. I. Survey of the literature.
    Lines RW
    Bull Parenter Drug Assoc; 1967; 21(4):113-7. PubMed ID: 4859718
    [No Abstract]   [Full Text] [Related]  

  • 4. Parenteral formulation. VI. Hydrolytic degradation of esters in parenteral solutions.
    Anschel J; Mollica JA; Lin KS
    Bull Parenter Drug Assoc; 1972; 26(6):271-89. PubMed ID: 4629105
    [No Abstract]   [Full Text] [Related]  

  • 5. Calibration of microscopes for measuring particles found in parenteral solutions.
    Lanier JM; Oxborrow GS; Kononen LT
    J Parenter Drug Assoc; 1978; 32(3):145-8. PubMed ID: 248420
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacterial content control and study of aseptic procedure in preparation of infusion solutions].
    Bábik I; Sagáth J
    Pharm Prax; 1968; 2():34-7. PubMed ID: 5731460
    [No Abstract]   [Full Text] [Related]  

  • 7. Preformulation screening of antioxidant efficiency in parenteral solutions.
    Akers MJ
    J Parenter Drug Assoc; 1979; 33(6):346-56. PubMed ID: 261586
    [No Abstract]   [Full Text] [Related]  

  • 8. [Summary of the discussion on the subject of: "technical problems in the production and use of infusion solutions"].
    Klin Anasthesiol Intensivther; 1977; (14):95-105. PubMed ID: 926695
    [No Abstract]   [Full Text] [Related]  

  • 9. Particulate matter contamination associated with automated compounding TPN solutions.
    Quercia RA
    Am J Hosp Pharm; 1988 Nov; 45(11):2324-5. PubMed ID: 3147592
    [No Abstract]   [Full Text] [Related]  

  • 10. [Storage capabilities of individually prepared infusion solutions].
    Bánhalmi Z; Korbély I; Kurucz T; Mohr T
    Acta Pharm Hung; 1979 Jul; 49(4):145-59. PubMed ID: 474138
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biopharmaceutical aspects of parenteral drug formulations].
    Pflegel H
    Pharmazie; 1982 Apr; 37(4):307-18. PubMed ID: 7048344
    [No Abstract]   [Full Text] [Related]  

  • 12. [Basis of infusion solutions. III. Systematization and directions for the use of infusion solutions].
    Schmitz JE; Ahnefeld FW
    Beitr Infusionther Klin Ernahr; 1980; 5():29-47. PubMed ID: 7192092
    [No Abstract]   [Full Text] [Related]  

  • 13. Compatibility of amphotericin B with drugs used to reduce adverse reactions.
    Gotz VP; Mar DD; Roche JJ
    Am J Hosp Pharm; 1981 Mar; 38(3):378-9. PubMed ID: 7223754
    [No Abstract]   [Full Text] [Related]  

  • 14. Bulk compounding technology.
    Am J Hosp Pharm; 1968 Jun; 25(6):320. PubMed ID: 5656779
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of stability and expiration time of infusion solutions].
    Opletal Z; Seidl R; Blazek J
    Cesk Farm; 1966 Jan; 15(1):34-8. PubMed ID: 5907952
    [No Abstract]   [Full Text] [Related]  

  • 16. Particulate matter in parenteral products: a review.
    Borchert SJ; Abe A; Aldrich DS; Fox LE; Freeman JE; White RD
    J Parenter Sci Technol; 1986; 40(5):212-41. PubMed ID: 3540253
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quality control of infusion solutions. I. Foreign particles in infusion solutions].
    van den Bemd AA
    Pharm Weekbl; 1969 Sep; 104(39):1205-9. PubMed ID: 5345140
    [No Abstract]   [Full Text] [Related]  

  • 18. [Special problems in the development of modern infusion solutions].
    Frank P
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1970 Mar; 40(3):77-88. PubMed ID: 5467832
    [No Abstract]   [Full Text] [Related]  

  • 19. In-use physicochemical and microbiological stability of biological parenteral products.
    Ricci MS; Frazier M; Moore J; Cromwell M; Galush WJ; Patel AR; Adler M; Altenburger U; Grauschopf U; Goldbach P; Fast JL; Krämer I; Mahler HC
    Am J Health Syst Pharm; 2015 Mar; 72(5):396-407. PubMed ID: 25694415
    [No Abstract]   [Full Text] [Related]  

  • 20. Stability of parenteral midazolam in an oral formulation.
    Walker SE; Grad HA; Haas DA; Mayer A
    Anesth Prog; 1997; 44(1):17-22. PubMed ID: 9481976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.